ArticleNeuroradiology2026
Differentiation of normal pressure hydrocephalus from alzheimer's and Parkinson's Diseases using the splenial angle measured on brain CT: diagnostic performance and reliability study.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough MRI and diffusion tensor imaging (DTI) based studies have evaluated the Splenial Angle (SA) in distinguishing normal pressure hydrocephalus (NPH), its reproducibility and diagnostic utility on CT remain untested.
objectiveTo assess the diagnostic performance and intra/inter-observer repeatability of CT-derived SA measurements for differentiating NPH from Alzheimer's and Parkinson's diseases. MATERIALS AND
methodsThis retrospective study included 325 individuals: 87 with NPH, 71 with Alzheimer's disease, 66 with Parkinson's disease, and 101 healthy controls. Evans Index (EI), Callosal Angle (CA), and SA were measured on brain CT images. Two radiologists assessed intra- and inter-observer repeatability. Continuous variables were analyzed using ANOVA, categorical variables using Chi-square tests, and Receiver Operating Characteristic (ROC) analysis determined diagnostic performance.
resultsEI, CA, and SA differed significantly between the NPH group and the other groups (p < 0.001). The SA showed the highest diagnostic accuracy for NPH (AUC = 0.999; cut-off = 49.5°; sensitivity = 0.996; specificity = 0.989; LR + = 86.63; LR- = 0.004). The CA also demonstrated strong performance (AUC = 0.993; cut-off = 87.5°). The EI achieved high accuracy (AUC = 0.928) but was less specific. In the Alzheimer's and Parkinson's groups, these measurements had limited discriminatory ability. Intra- and inter-observer agreement was high for all three parameters, with the SA showing the greatest repeatability.
conclusionThe SA can be used as a reliable CT-based marker to help distinguish NPH from neurodegenerative diseases, serving as a supportive imaging parameter in clinical assessment.
Indexed as
Identifiers
42105113What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.